As rates of obesity have increased over the last 20 years, demand for medicines to treat obesity has soared, resulting in shortages of critical ingredients needed to manufacture these drugs. These treatments – called GLP-1s – help manage type 2 diabetes and effectively promote weight loss. Fortunately, the Food and Drug Administration (FDA) recently announced […]
Author Archives: Ronald P. Jordan
Ronald P. Jordan, RPh is the Founding and Emeritus Dean at Chapman University School of Pharmacy and former president of the American Pharmacists Association (APhA). He wrote this for InsideSources.com.

